Clinical predictors of bioterrorism-related inhalational anthrax

Lancet. 2004;364(9432):449-52. doi: 10.1016/S0140-6736(04)16769-X.

Abstract

Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerosols
  • Anthrax / diagnosis*
  • Anthrax / transmission
  • Bacillus anthracis / physiology
  • Bioterrorism*
  • Diagnosis, Differential
  • Humans
  • Influenza, Human / diagnosis
  • Pneumonia / diagnosis
  • Respiratory Tract Infections / diagnosis*
  • Respiratory Tract Infections / transmission
  • Spores, Bacterial

Substances

  • Aerosols